Pretreatment Quality of Life Is an Independent Prognostic Factor for Overall Survival in Patients with Advanced Stage Non-small Cell Lung Cancer

HYPOTHESIS: We conducted this pooled analysis to assess the prognostic value of pretreatment Quality of Life (QOL) assessments on overall survival (OS) in advanced non-small cell lung cancer (NSCLC). METHODS: Four hundred twenty patients with advanced NSCLC (stages IIIB with pleural effusion and IV)...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Qi, Yingwei, Schild, Steven E., Mandrekar, Sumithra J., Tan, Angelina D., Krook, James E., Rowland, Kendrith M., Garces, Yolanda I., Soori, Gamini S., Adjei, Alex A., Sloan, Jeff A.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2009
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2954489/
https://ncbi.nlm.nih.gov/pubmed/19546817
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/JTO.0b013e3181ae27f5
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky